HMGB1 and plasma cell myeloma: For instance, MALAT1 increases HMGB1 levels in hepatic injury, colorectal cancer, and multiple myeloma, often acting as a competitive endogenous RNA (ceRNA) for miRNAs that target HMGB1 [61].